摘要
急性肾衰竭(ARF)是恶性肿瘤的一种严重并发症,导致显著的发病率和死亡率。急性肾衰竭是一种常见的部分多器官功能障碍的危重患者报告的死亡率从72%癌症85%人需要肾脏替代治疗的患者。导致ARF的癌症患者的途径是ARF在其他条件的共同发展。然而,导致急性肾功能衰竭的发展的某些因素可能是肿瘤或肿瘤治疗相关。本综述的目的是在危重患者给肾脏疾病的具体方面(CICPs),概述CICPs的原因和ARF描述这些并发症的管理的最新进展,包括治疗的毒性和骨髓移植(BMT)。急性肾功能衰竭的预防是必须的,因此在CICPs ARF的可能的治疗方法进行了讨论。
关键词: 急性肾功能衰竭,肿瘤溶解综合征,肝细胞癌,多发性骨髓瘤,淋巴瘤。
Current Medicinal Chemistry
Title:Acute Renal Failure in Different Malignant Tumors
Volume: 23 Issue: 19
Author(s): Sanja Radojevic-Skodric, Ljiljana Bogdanovic, Milena Jovanovic, Ivana Baralic, Zoran Dzamic, Ron Gordon, Simona Ognjanovic and Gordana Basta-Jovanovic
Affiliation:
关键词: 急性肾功能衰竭,肿瘤溶解综合征,肝细胞癌,多发性骨髓瘤,淋巴瘤。
摘要: Acute renal failure (ARF) represents a severe complication of malignancies, that causes significant morbidity and mortality. ARF is a common part of multiple organ dysfunction in critically ill patients with cancer with reported mortality rates from 72% to 85% in patients who need renal replacement therapy. The pathways leading to ARF in cancer patients are common to the development of ARF in other conditions. However, certain factors leading to the development of ARF may be associated to the tumor or to the tumor therapy. The purpose of this review is to give specific aspects of renal disease in critically ill cancer patients (CICPs), to overview the causes of ARF in CICPs and to describe recent progress in the management of these complications, including treatment toxicity and bone marrow transplantation (BMT). The prevention of ARF is obligatory and therefore the possible treatments of ARF in CICPs are also discussed.
Export Options
About this article
Cite this article as:
Sanja Radojevic-Skodric, Ljiljana Bogdanovic, Milena Jovanovic, Ivana Baralic, Zoran Dzamic, Ron Gordon, Simona Ognjanovic and Gordana Basta-Jovanovic , Acute Renal Failure in Different Malignant Tumors, Current Medicinal Chemistry 2016; 23 (19) . https://dx.doi.org/10.2174/0929867323666160407113245
DOI https://dx.doi.org/10.2174/0929867323666160407113245 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives
Current Pharmaceutical Design Surgical Management of Mullerian Duct Anomalies
Current Women`s Health Reviews Current Management of Fetal and Neonatal Renal Tumors
Current Pediatric Reviews Hypoxic Regulation of Metastasis via Hypoxia-Inducible Factors
Current Molecular Medicine Imaging in the Age of Molecular Medicine: Monitoring of Anti-Angiogenic Treatments
Current Pharmaceutical Biotechnology Conjugation of Phthalocyanine Photosensitizer with Poly(amidoamine) Dendrimer: Improved Solubility, Disaggregation and Photoactivity Against HepG2 Cells
Current Cancer Drug Targets Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
Anti-Cancer Agents in Medicinal Chemistry Editorial: Fighting Against Kidney Injury
Current Protein & Peptide Science A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Current Medicinal Chemistry Interaction of Drug or Food with Drug Transporters in Intestine and Liver
Current Drug Metabolism New Organ-Specific Drug Strategies Interfering in Signaling Pathways: Kinase Inhibitors and Other New Developmental Drugs in HCC
Current Signal Transduction Therapy Smart Delivery and Controlled Drug Release with Gold Nanoparticles: New Frontiers in Nanomedicine
Recent Patents on Nanomedicine Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer
Current Drug Targets Current Strategy for Cisplatin Delivery
Current Cancer Drug Targets F508del-CFTR Rescue: A Matter of Cell Stress Response
Current Pharmaceutical Design Medicinal Chemistry Design Principles for Liver Targeting Through OATP Transporters
Current Topics in Medicinal Chemistry Targeting the AKT Pathway in Glioblastoma
Current Pharmaceutical Design IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets Impact on DNA Methylation in Cancer Prevention and Therapy by Bioactive Dietary Components
Current Medicinal Chemistry Detection of Tumor Markers with ProteinChip® Technology
Current Pharmaceutical Biotechnology